About
Neurodegenerative Treatments
Areas of Focus
Categories
Drug Delivery DeviceUncategorized Medical Device
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
41
By Phase
PHASE1/PHASE2: 3
By Status
RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT07214285Collaborator
Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)
PHASE1/PHASE2Recruiting
1 participants
Started: Oct 1, 2025 · Completed: Oct 30, 2025
NCT04332276Collaborator
Dopaminergic RestauratIon by IntraVEntriculaire Administration
PHASE1/PHASE2Completed
12 participants
Started: Sep 18, 2020 · Completed: May 6, 2024
NCT04299191Collaborator
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
PHASE1/PHASE2Recruiting
28 participants
Started: Sep 1, 2020 · Completed: Sep 30, 2025
Locations (1)
Headquarters
Lille, France
Map
Loading map...